Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1159 |
---|---|
Product Name | Anti-Human IL1B Recombinant Antibody(Canakinumab) |
Molecular Name | Canakinumab |
Alias | Anti-IL1B Recombinant Antibody, Research Grade Canakinumab |
CAS Number | 914613-48-2 |
Molecular Weight | 145.2 kDa |
Target | IL1B[Homo sapiens] |
Isotype | IgG1 Kappa |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | FCM, IP, ELISA, Neut, FuncS, IF, IHC |
Buffer | PBS, pH7.5 |
Background | Canakinumab (INN), sold under the brand name Ilaris is a medication for the treatment of systemic juvenile idiopathic arthritis (SJIA) and active Still's disease, including adult-onset Still's disease (AOSD). It is a human monoclonal antibody targeted at interleukin-1 beta. It has no cross-reactivity with other members of the interleukin-1 family, including interleukin-1 alpha. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |